FLAVYA(TM)

Products

Information

Flavya(TM) products are injectable medical devices containing native hyaluronic acid (HA). Flavya(TM) complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin. Two variants for tailored treatment: Excellence (44 mg HA, 2.2%, 100-200 Pas) for thicker skin/deeper wrinkles, injected into deep/medium-deep dermis; Medium (32 mg HA, 1.6%, <100 Pas) for thin, delicate skin, injected into the reticular dermis

Product Categories

Finished Dosage Forms
- Injectables

Distribution Areas

OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)

Supplied From

Poland

Biovico Sp. z o.o.Biovico & Implai, part of the Wilandt Brothers (HLDG) holding, form a complementary HealthTech ecosystem spanning Pharmaceuticals and Medical Devices. Biovico is a biotechnology manufacturer delivering clinically tested solutions in esthetic medicine and veterinary care, with patient wellbeing at its core. Implai develops innovative medical solutions for orthopedics, spine, dental and veterinary surgery, empowering physicians to deliver superior clinical outcomes. Backed by strong R&D, certified manufacturing and a global distributor network, Biovico & Implai unite scientific rigor with clinical relevance for patients and healthcare partners worldwide.

FLAVYA(TM)

Information

Log in